Effects of the Antipsychotic Risperidone on Dopamine Synthesis in Human Brain Measured by Positron Emission Tomography with l-[β-11C]DOPA: A Stabilizing Effect for Dopaminergic Neurotransmission?

Effects of antipsychotic drugs have widely been considered to be mediated by blockade of postsynaptic dopamine D2 receptors. Effects of antipsychotics on presynaptic functions of dopaminergic neurotransmission might also be related to therapeutic effects of antipsychotics. To investigate the effects of antipsychotics on presynaptic functions of dopaminergic neurotransmission in relation with occupancy of dopamine D2 receptors, changes in dopamine synthesis capacity by antipsychotics and occupancy of dopamine D2 receptors were measured by positron emission tomography (PET) in healthy men. PET studies using [11C]raclopride and l-[β-11C]DOPA were performed under resting condition and oral administration of single dose of the antipsychotic drug risperidone on separate days. Although occupancy of dopamine D2 receptors corresponding dose of risperidone was observed, the changes in dopamine synthesis capacity by the administration of risperidone were not significant, nor was the relation between the occupancy of dopamine D2 receptors and these changes. A significant negative correlation was observed between the baseline dopamine synthesis capacity and the changes in dopamine synthesis capacity by risperidone, indicating that this antipsychotic can be assumed to stabilize the dopamine synthesis capacity. The therapeutic effects of risperidone in schizophrenia might be related to such stabilizing effects on dopaminergic neurotransmission responsivity.

[1]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[2]  M. Frank,et al.  Striatal Dopamine Predicts Outcome-Specific Reversal Learning and Its Sensitivity to Dopaminergic Drug Administration , 2009, The Journal of Neuroscience.

[3]  Paul Cumming,et al.  Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects , 2008, NeuroImage.

[4]  R. Roth,et al.  Clozapine Normalizes Prefrontal Cortex Dopamine Transmission in Monkeys Subchronically Exposed to Phencyclidine , 2008, Neuropsychopharmacology.

[5]  M. D’Esposito,et al.  Working Memory Capacity Predicts Dopamine Synthesis Capacity in the Human Striatum , 2008, The Journal of Neuroscience.

[6]  Shitij Kapur,et al.  Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. , 2007, The American journal of psychiatry.

[7]  Harumasa Takano,et al.  Mapping of central dopamine synthesis in man, using positron emission tomography with l-[β-11C]DOPA , 2007, Annals of nuclear medicine.

[8]  Ryuji Nakao,et al.  Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[&bgr;-11C]DOPA , 2006, Nuclear medicine communications.

[9]  Hans-Georg Buchholz,et al.  Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge , 2006, NeuroImage.

[10]  Sylvain Houle,et al.  Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine , 2004, Synapse.

[11]  Albert Gjedde,et al.  Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo , 2003, Neuropsychopharmacology.

[12]  A. Gjedde,et al.  Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo , 2001, Synapse.

[13]  K. Kitahama,et al.  Autoradiographic studies using l-[14C]DOPA and l-[3H]DOPA reveal regional Na+-dependent uptake of the neurotransmitter candidate l-DOPA in the CNS , 2001, Neuroscience.

[14]  H. McFarlane,et al.  M100,907, a selective 5-HT2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex , 2001, Brain Research.

[15]  G. Antoni,et al.  Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone , 1998, Neuropharmacology.

[16]  A. Gjedde,et al.  In Vivo Regulation of DOPA Decarboxylase by Dopamine Receptors in Rat Brain , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[19]  T. Svensson,et al.  Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain , 1996, Psychopharmacology.

[20]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Leysen,et al.  Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. , 1994, The Journal of clinical psychiatry.

[22]  A. Boulton,et al.  Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. , 1993, European journal of pharmacology.

[23]  Christer Halldin,et al.  5-HT2 and D2 dopamine receptor occupancy in the living human brain , 1993, Psychopharmacology.

[24]  A. Boulton,et al.  Regulation of Aromatic l‐Amino Acid Decarboxylase by Dopamine Receptors in the Rat Brain , 1992, Journal of neurochemistry.

[25]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[26]  Alan C. Evans,et al.  Dopa decarboxylase activity of the living human brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Karl J. Friston,et al.  The Relationship between Global and Local Changes in PET Scans , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  P. Hicks.  The effect of serotonergic agents on haloperidol-induced catalepsy , 1989, Schizophrenia Research.

[29]  J. Kelsoe,et al.  Plasma Homovanillic Acid as an Index of Central Dopaminergic Activity: Studies in Schizophrenic Patients , 1988, Annals of the New York Academy of Sciences.

[30]  A. Friedhoff,et al.  Plasma homovanillic acid as a predictor of response to neuroleptics. , 1988, Archives of general psychiatry.

[31]  J. Gerlach,et al.  Behavioral aspects of serotonin-dopamine interaction in the monkey. , 1985, European journal of pharmacology.

[32]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  A. Crane,et al.  Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates , 1979, Brain Research.

[35]  J. Balsara,et al.  Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy , 1979, Psychopharmacology.

[36]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[37]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[38]  O. Hornykiewicz,et al.  OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN , 1972, Journal of neurochemistry.

[39]  D F Sharman,et al.  Effect of drugs used in psychoses on cerebral dopamine metabolism , 1970, British journal of pharmacology.

[40]  B. Långström,et al.  Brain kinetics of L-[Β-11 C]DOPA in humans studied by positron emission tomography , 2005, Journal of Neural Transmission / General Section JNT.

[41]  J. Baron,et al.  Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels , 2004, Psychopharmacology.

[42]  D. Newport,et al.  A Single Scatter Simulation Technique for Scatter Correction in 3D PET , 1996 .

[43]  Ronald J. Faber,et al.  Compulsive buying: descriptive characteristics and psychiatric comorbidity. , 1994, The Journal of clinical psychiatry.

[44]  G. Sedvall,et al.  Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. , 1988, Archives of general psychiatry.

[45]  A. Gjedde.  Exchange diffusion of large neutral amino acids between blood and brain , 1988 .